News Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology Therapeutics Staff September 11, 2023 Iframe sync Post navigation Previous: XORTX Announces Participation at Upcoming Investor ConferencesNext: InflaRx Announces Positive Topline Results from the Single Ascending Dose (SAD) Phase I Study with C5aR Inhibitor INF904 More Stories Brain Cancer News Kanazawa University research: Scientists develop a new method to measure cellular energy in real time Staff November 21, 2025 Diagnostics Healthcare News Oracle Names Stephen Rusckowski to the Board of Directors Staff November 21, 2025 Cancer Clinical Trial Healthcare News Pharmaceutical Onco-Innovations Advances Optimization and Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services to Support Future Phase 1 Clinical Studies Staff November 20, 2025
